Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 662 results for "zydus group"

Zydus Cadila gets approval for Pyridostigmine Bromide Tablets
India Infoline

Cadila Healthcare gains after receiving market authorisation f...

Cadila Healthcare rose 1.29% to Rs 1,820 at 15:15 IST on BSE after the company said the Zydus group has received the market authorisation from the United States Food & Drug Administration to market Morphine Sulfate ER tablet. The company made announcement ... Business Standard, 2 days ago
[x]  

3 images for "zydus group"

Moneycontrol.com, 2 days ago
Times of India, 1 month ago
I Stock Analyst, 2 months ago
DNA India

Zydus Gets US Regulator's Nod for Pain Reliever Tablets

New Delhi: Pharmaceuticals major Zydus Group on Wednesday announced receipt of approval from the US Food and Drug Administration (FDA) to sell chronic pain reliever morphine sulfate tablets. "The product used in treatment of chronic pain or cancer ...
 NDTV Profit2 days ago Zydus gets USFDA nod to sell morphine sulfate tablets  DNA India3 days ago Zydus gets USFDA nod for morphine sulfate tablets  Money Control2 days ago
[x]  

Cadila Healthcare to acquire Claris Lifesciences for Rs 3,400 crore

Mumbai: Cadila Healthcare, the Zydus Cadilla Group flagship, has emerged as the frontrunner to acquire the generic sterile injectables business of Ahmedabad-headquartered Claris Lifesciences Ltd (CLL) trumping several domestic and global peers who ...
 India Brand Equity Foundation1 month ago Cadila Healthcare eyes Claris arm for Rs 3,400 crore  Economic Times1 month ago Buy Cadila Healthcare; tgt of Rs 1920: Firstcall Research  Moneycontrol.com1 month ago Cadila Healthcare trumps peers, in talks to acquire Claris Lifesciences for whooping Rs 3,400 crore  Business Insider India1 month ago
Times of India

Zydus Cadila 2014-15 net up 43%

AHMEDABAD: Zydus Cadila registered a net profit of Rs. 1151 crores for the year ended 31st March 2015 — up by 43% from Rs. 804 crores in the previous year. During the year, the company registered gross sales of Rs. 8658 crores, up by 20% from Rs.
 Times of India1 month ago Zydus Cadila Q4 net up 46%; revenues jump 16%  Smart Investor1 month ago Zydus Cadila Q4 net profit up 46%  Livemint.com1 month ago Zydus aims to develop drug for fatty liver disease  Business Standard India1 month ago
[x]  

French Islamic group on trial after Jewish "target" list found

Forest cover stopped decreasing in last one year: Javadekar Cyclonic Storm 'Ashobba' over east-central Arabian Sea: IMD Modi statements in B'desh show lack of grace, lowered dignity of PM's office: Cong Dacoits steal 150 sovereigns gold jewels, Rs 2 ...
 United News of India3 weeks ago

Indonesian group plans challenge to bid to scrap $20 bln in fuel subsidies

K'taka to add 9500 mw through solar energy: Minister Railway Board delegation to visit China, Japan from June 12 Spicejet plans to add 7 aircraft to its fleet Vijai Sharma appointed new Central Information Commissioner Yechury says all three sectors ...
 United News of India3 weeks ago Vijai Sharma appointed new Central Information Commissioner  United News of India3 weeks ago Railway Board delegation to visit China, Japan from June 12  United News of India3 weeks ago K'taka to add 9500 mw through solar energy: Minister  United News of India3 weeks ago

Manoj Bhagat appointed group creative director, DDB Mudra West

has earlier worked with agencies such as Grey Worldwide, L&K Saatchi & Saatchi and Access Leo Burnett, Nairobi. DDB Mudra West has roped in Manoj Bhagat as group creative director. Bhagat joins the agency's Mumbai office from Greenapple Design, ...
 Agencyfaqs!1 month ago

Zydus to Present New Scientific Data on Lipaglyn (Saroglitazar), and Real World Data in Patients With Type 2 Diabetes at the American Diabetes Association 75th Scientific Sessions in Boston, USA

/PRNewswire/ -- Zydus Cadila, a leading global healthcare provider, today announced that new scientific and clinical data on Saroglitazar will be presented at the 75th Annual Scientific Sessions of the American Diabetes Association (ADA) in ...
 Barchart3 weeks ago Zydus Cadila to present new clinical data on Lipaglyn at AACE meeting in USA  PharmaBiz1 month ago
[x]  
Seeking Alpha

Pieris Pharmaceuticals Appoints Former Celgene and Sanofi Executive, Jean-Pierre Bizzari, M.D., to Its Board of Directors

FREISING, GERMANY Dr. Bizzari was the Executive Vice President, Group Head, Clinical Oncology Development at Celgene Corporation. Since joining Celgene in 2008, he directed the development and approval of a number of leading oncology products ...
 Digital Journal1 month ago Pieris Pharmaceuticals, Inc. (PIRS: OTC Pink Current) | Pieris Pharmaceuticals Prices Public Offering of Common Stock  OTC Markets3 days ago Pieris Pharmaceuticals Prices Public Offering of Common Stock  A.M. Best3 days ago PIES PHAR : Pieris Pharmaceuticals Prices Public Offering of Common Stock  4 Traders3 days ago
[x]  

TCPA FCC Petitions Tracker

Kelley Drye's Communications Practice Group presents this comprehensive tracker of active Telephone Consumer Protection Act (TCPA) petitions before the Federal Communications Commission (FCC). With the recent increase in litigation regarding alleged ...
 JD Supra1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus group
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less